Mite Infestations: Clinical Trials

14 trials for Mite Infestations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 14 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 314Completed 10, Unknown 2, Not yet recruiting 1, Recruiting 1

Follow Mite Infestations: new trials by email Literature Review of Mite Infestations trials Research Report on Mite Infestations

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Better Options for Lymphatic Filariasis Treatment
MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies
Phase 3RecruitingMedicines Development for Global Health51002026-09-282026-10-07
Therapy for Scabies With Two Differently Concentrated Permethrin Creams
5% Permethrin Creme, 10% Permethrin Creme - Scabies
Phase 3Not yet recruitingInfectopharm Arzneimittel GmbH2202024-05-012024-04-23
Sulfur vs. Different Regimes of Permethrin for Scabies
Permethrin Solution, Sulfur - Scabies
Phase 3CompletedDamascus University2502022-03-152024-05-02
Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)
InfectoScab 5 % Creme, Permethrin 10 % Creme, Driponin 3 mg Tabletten - Scabies
Phase 3UnknownInfectopharm Arzneimittel GmbH1832021-06-112021-08-26
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases
Phase 3UnknownLondon School of Hygiene and Tropical Medicine240002021-05-032022-02-24
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1 - Trachoma, Yaws
Phase 3CompletedLihir Medical Centre200002018-10-012019-02-28
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
Permethrin Cream 5% - Scabies
Phase 3CompletedSaptalis Pharmaceuticals LLC1262018-04-102020-10-23
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
Ivermectin, Permethrin 5%, Malathion Shampoo 0.5% - Scabies, Head Lice
Phase 3CompletedLondon School of Hygiene and Tropical Medicine1182017-08-012019-06-14
Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies
Permethrin Cream, 5%, Elimite™ Cream (permethrin) 5% - Scabies
Phase 3CompletedEncube Ethicals Pvt. Ltd.2542017-06-012019-03-26
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
spinosad topical suspension, 0.9%, Placebo - Scabies
Phase 3CompletedParaPRO LLC2802017-05-102021-05-21
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
spinosad topical suspension, 0.9%, Placebo - Scabies
Phase 3CompletedParaPRO LLC2912017-05-022021-05-19
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Permethrin Cream, 5%, Elimite - Scabies
Phase 3CompletedMayne Pharma International Pty Ltd1402016-11-012020-09-02
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults
Ivermectin, Permethrin - Scabies
Phase 3CompletedUniversity Hospital, Bordeaux10922016-01-192024-06-17
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
Permethrin - Scabies
Phase 3CompletedDr. Reddy's Laboratories Limited2502015-09-012016-10-14

Narrower conditions

Scabies (14)  ·  Elephantiasis, Filarial (3)  ·  Strongyloidiasis (3)  ·  Neglected Diseases (2)  ·  Ancylostomiasis (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)  ·  Parasitic Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Trachoma (1)  ·  Yaws (1)

Broader conditions

Ectoparasitic Infestations (14)  ·  Infections (14)  ·  Skin Diseases, Parasitic (14)  ·  Skin and Connective Tissue Diseases (14)  ·  Parasitic Diseases (13)  ·  Skin Diseases (13)  ·  Skin Diseases, Infectious (13)  ·  Filariasis (3)  ·  Helminthiasis (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Lymphatic Diseases (3)  ·  Lymphedema (3)  ·  Mosquito-Borne Diseases (3)  ·  Nematode Infections (3)

Interventions

Permethrin (6)  ·  Ivermectin (4)  ·  Albendazole (2)  ·  Suspensions (2)  ·  spinosad (2)  ·  Azithromycin (1)  ·  Diethylcarbamazine (1)  ·  Sulfur (1)

Sponsors

Infectopharm Arzneimittel GmbH (2)  ·  London School of Hygiene and Tropical Medicine (2)  ·  ParaPRO LLC (2)  ·  Damascus University (1)  ·  Dr. Reddy's Laboratories Limited (1)  ·  Encube Ethicals Pvt. Ltd. (1)  ·  Lihir Medical Centre (1)  ·  Mayne Pharma International Pty Ltd (1)  ·  Medicines Development for Global Health (1)  ·  Saptalis Pharmaceuticals LLC (1)  ·  University Hospital, Bordeaux (1)

Countries

United States (6)  ·  El Salvador (2)  ·  Fiji (1)  ·  France (1)  ·  Germany (1)  ·  Guadeloupe (1)  ·  Guinea-Bissau (1)  ·  Panama (1)  ·  Papua New Guinea (1)  ·  Puerto Rico (1)  ·  Solomon Islands (1)  ·  Syria (1)

Top investigators

Kerry W Mettert, MBA (2)  ·  Anna R Last, MBChB PhD (1)  ·  Ashis Patnaik, MD (1)  ·  Bruneau Giraudeau, Doctor (1)  ·  Lucy John, MD (1)  ·  Phoevos Hughes, JD (1)  ·  Prasanna Ganapathi, MD (1)  ·  Pratik Kamani (1)  ·  Shilpi Dhawan, MD (1)

Results publications

PMID 30252856, PMID 37419638, PMID 39551062, PMID 41494769

NIH funding

2019 (1), 2023 (1)